Cite
HARVARD Citation
Imbimbo, B. et al. (2012). Solanezumab for the treatment of mild-to-moderate Alzheimer''s disease. Expert review of clinical immunology. pp. 135-149. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Imbimbo, B. et al. (2012). Solanezumab for the treatment of mild-to-moderate Alzheimer''s disease. Expert review of clinical immunology. pp. 135-149. [Online].